NASDAQ : GPCR
Structure Therapeutics Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 21.94 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 1.56B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Selling, General & Admin | 73.81M | 61.55M | 49.41M | 32.67M | 16.37M | 8.59M |
| Research & Development | 294.24M | 225.25M | 108.81M | 70.10M | 36.19M | 29.11M |
| Other Operating Expenses | -100.00M | -100.00M | ||||
| Operating Expenses | 268.06M | 186.81M | 158.23M | 102.78M | 52.56M | 37.70M |
| Operating Income | -268.06M | -186.81M | -158.23M | -102.78M | -52.56M | -37.70M |
| Interest Expense | -122.00K | |||||
| Interest & Investment Income | 46.57M | 35.87M | 36.01M | 13.39M | 1.26M | |
| EBT Excluding Unusual Items | -221.48M | -150.94M | -122.22M | -89.38M | -51.30M | -37.82M |
| Gain (Loss) on Sale of Assets | 10.25M | 10.25M | ||||
| Pretax Income | -214.13M | -140.69M | -122.22M | -89.38M | -51.30M | -37.82M |
| Income Tax Expense | 702.00K | 515.00K | 310.00K | 236.00K | 17.00K | 231.00K |
| Net Income | -214.84M | -141.20M | -122.53M | -89.62M | -51.32M | -38.05M |
| Preferred Dividends & Other Adjustments | 1.51M | 5.72M | ||||
| Net Income to Common | -214.84M | -141.20M | -122.53M | -89.62M | -52.84M | -43.77M |
| Shares Outstanding (Basic) | 66.75M | 59.20M | 52.64M | 36.73M | 3.19M | 2.71M |
| Shares Outstanding (Diluted) | 66.75M | 59.20M | 52.64M | 36.73M | 3.19M | 2.71M |
| EPS (Basic) | -3.22 | -2.39 | -2.33 | -2.44 | -16.54 | -16.13 |
| EPS (Diluted) | -3.22 | -2.39 | -2.33 | -2.44 | -16.54 | -16.13 |
| Free Cash Flow | -224.50M | -225.81M | -117.93M | -81.66M | -46.27M | -33.37M |
| Free Cash Flow Per Share | -3.36 | -3.81 | -2.24 | -2.22 | -14.48 | -12.30 |
| EBITDA | -265.79M | -185.13M | -157.23M | -102.46M | -52.28M | -37.62M |
| D&A For EBITDA | 2.27M | 1.68M | 996.00K | 316.00K | 277.00K | 72.00K |
| EBIT | -268.06M | -186.81M | -158.23M | -102.78M | -52.56M | -37.70M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 272.64M | 799.62M | 169.51M | 129.79M | 26.09M | 105.31M |
| Short-Term Investments | 1.07B | 646.57M | 714.01M | 337.53M | 64.75M | 2.00M |
| Cash & Short-Term Investments | 1.34B | 1.45B | 883.52M | 467.32M | 90.84M | 107.31M |
| Other Receivables | 100.00M | |||||
| Receivables | 100.00M | |||||
| Prepaid Expenses | 29.37M | 24.11M | 7.69M | 6.29M | 2.25M | 1.94M |
| Total Current Assets | 1.37B | 1.57B | 891.21M | 473.61M | 93.09M | 109.25M |
| Property, Plant & Equipment | 12.39M | 12.90M | 7.01M | 8.36M | 1.29M | 1.79M |
| Long-Term Deferred Charges | 3.40M | 100.00K | ||||
| Other Long-Term Assets | 40.99M | 717.00K | 5.11M | 45.00K | 63.00K | 11.00K |
| Total Assets | 1.43B | 1.58B | 903.33M | 482.02M | 97.84M | 111.16M |
| Accounts Payable | 11.13M | 13.86M | 8.02M | 4.74M | 6.01M | 3.48M |
| Accrued Expenses | 52.39M | 46.54M | 26.30M | 18.56M | 6.57M | 4.59M |
| Current Portion of Leases | 2.60M | 2.88M | 1.70M | 1.44M | 260.00K | 349.00K |
| Current Income Taxes Payable | 174.00K | 231.00K | ||||
| Total Current Liabilities | 66.11M | 63.28M | 36.02M | 24.74M | 13.01M | 8.66M |
| Long-Term Leases | 3.63M | 3.61M | 2.16M | 4.01M | 272.00K | |
| Other Long-Term Liabilities | 1.26M | 647.00K | 302.00K | 298.00K | ||
| Total Liabilities | 71.01M | 67.54M | 38.49M | 29.05M | 13.01M | 8.93M |
| Common Stock | 21.00K | 21.00K | 17.00K | 14.00K | 1.00K | 1.00K |
| Additional Paid-In Capital | 2.01B | 1.99B | 1.19B | 659.00M | 1.92M | |
| Retained Earnings | -652.43M | -470.30M | -329.10M | -206.57M | -116.95M | -64.74M |
| Comprehensive Income & Other | -3.44M | 1.05M | 914.00K | 521.00K | -110.00K | |
| Total Common Equity | 1.35B | 1.52B | 864.84M | 452.97M | -115.14M | -64.73M |
| Shareholders' Equity | 1.35B | 1.52B | 864.84M | 452.97M | 84.83M | 102.22M |
| Total Liabilities & Equity | 1.43B | 1.58B | 903.33M | 482.02M | 97.84M | 111.16M |
| Total Debt | 6.23M | 6.49M | 3.86M | 5.45M | 260.00K | 621.00K |
| Net Cash (Debt) | 1.34B | 1.44B | 879.66M | 461.87M | 90.58M | 106.69M |
| Net Cash Per Share | 20.02 | 24.32 | 16.71 | 12.57 | 28.35 | 39.31 |
| Filing Date Shares Outstanding | 71.31M | 70.84M | 57.34M | 46.60M | 38.24M | 3.63M |
| Total Common Shares Outstanding | 71.22M | 70.84M | 57.29M | 46.41M | 3.51M | 3.63M |
| Working Capital | 1.31B | 1.51B | 855.19M | 448.87M | 80.08M | 100.59M |
| Book Value Per Share | 19.02 | 21.41 | 15.10 | 9.76 | -32.81 | -17.83 |
| Tangible Book Value | 1.35B | 1.52B | 864.84M | 452.97M | -115.14M | -64.73M |
| Tangible Book Value Per Share | 19.02 | 21.41 | 15.10 | 9.76 | -32.81 | -17.83 |
| Machinery | 6.81M | 3.75M | 2.51M | 1.27M | 1.15M | |
| Construction In Progress | 1.28M | |||||
| Leasehold Improvements | 1.54M | 1.36M | 1.36M | 109.00K | 110.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -214.84M | -141.20M | -122.53M | -89.62M | -51.32M | -38.05M |
| Depreciation & Amortization | 2.27M | 1.68M | 996.00K | 316.00K | 277.00K | 72.00K |
| Other Amortization | 47.00K | |||||
| Loss (Gain) From Sale of Assets | -10.25M | -10.25M | ||||
| Loss (Gain) From Sale of Investments | -12.69M | -15.59M | -18.46M | -5.97M | -905.00K | 27.00K |
| Stock-Based Compensation | 39.84M | 28.99M | 18.79M | 8.19M | 2.51M | 1.49M |
| Other Operating Activities | 2.62M | 2.21M | 1.60M | 634.00K | 347.00K | 194.00K |
| Change in Accounts Receivable | -100.00M | |||||
| Change in Accounts Payable | 2.14M | 4.76M | 3.31M | -860.00K | 2.15M | 1.90M |
| Change in Other Net Operating Assets | -29.39M | 7.19M | -343.00K | 7.83M | 815.00K | 2.17M |
| Operating Cash Flow | -220.29M | -222.20M | -116.64M | -79.49M | -46.12M | -32.16M |
| Capital Expenditures | -4.21M | -3.61M | -1.29M | -2.17M | -155.00K | -1.21M |
| Sale of Property, Plant & Equipment | 10.25M | 10.25M | ||||
| Investment in Securities | -421.67M | 83.16M | -357.62M | -266.18M | -61.95M | 19.07M |
| Investing Cash Flow | -415.63M | 89.80M | -358.91M | -268.34M | -62.11M | 17.86M |
| Issuance of Common Stock | 766.63M | 765.15M | 517.06M | 473.10M | 33.00K | 11.00K |
| Repurchase of Common Stock | -3.04M | -618.00K | -6.00K | |||
| Other Financing Activities | -2.06M | -2.02M | -1.80M | -21.57M | -2.51M | 3.24M |
| Financing Cash Flow | 761.53M | 762.52M | 515.26M | 451.53M | 29.01M | 103.25M |
| Net Cash Flow | 125.61M | 630.11M | 39.72M | 103.70M | -79.21M | 88.95M |
| Free Cash Flow | -224.50M | -225.81M | -117.93M | -81.66M | -46.27M | -33.37M |
| Free Cash Flow Per Share | -3.36 | -3.81 | -2.24 | -2.22 | -14.48 | -12.30 |
| Levered Free Cash Flow | -119.06M | -180.03M | -70.78M | -51.38M | -26.08M | -18.79M |
| Unlevered Free Cash Flow | -119.06M | -180.03M | -70.78M | -51.38M | -26.08M | -18.76M |
| Change in Working Capital | -27.25M | -88.04M | 2.96M | 6.97M | 2.97M | 4.06M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 1.56B | 4.81B | 1.55B | 1.99B | ||
| Enterprise Value | 223.12M | 4.02B | 642.01M | 1.79B | ||
| Last Close Price | 21.87 | 69.55 | 27.12 | 40.76 | ||
| PB Ratio | 1.15 | 3.17 | 1.80 | 4.40 | ||
| P/TBV Ratio | 1.15 | 3.17 | 1.80 | 4.40 | ||
| Debt / Equity Ratio | 0.01 | 0.00 | 0.00 | 0.01 | 0.00 | 0.01 |
| Net Debt / Equity Ratio | -0.99 | -0.95 | -1.02 | -1.02 | -1.07 | -1.04 |
| Net Debt / EBITDA Ratio | 5.03 | 7.78 | 5.59 | 4.51 | 1.73 | 2.84 |
| Net Debt / FCF Ratio | 5.95 | 6.38 | 7.46 | 5.66 | 1.96 | 3.20 |
| Quick Ratio | 20.31 | 24.43 | 24.53 | 18.89 | 6.98 | 12.39 |
| Current Ratio | 20.75 | 24.81 | 24.74 | 19.14 | 7.16 | 12.62 |
| Return on Equity (ROE) | -20.21% | -11.86% | -18.59% | -33.33% | -54.87% | -55.24% |
| Return on Assets (ROA) | -14.95% | -9.39% | -14.28% | -22.16% | -31.44% | -31.44% |
| Return on Capital Employed (ROCE) | -19.70% | -12.30% | -18.20% | -22.50% | -62.00% | -36.80% |
| Earnings Yield | -14.72% | -2.94% | -7.89% | -4.50% | ||
| FCF Yield | -14.40% | -4.70% | -7.59% | -4.10% | ||
| Buyback Yield / Dilution | -16.35% | -12.46% | -43.31% | -1,049.81% | -17.72% | -30.01% |